PL3393565T3 - Kapsułki z cząsteczkami nikotyny - Google Patents

Kapsułki z cząsteczkami nikotyny

Info

Publication number
PL3393565T3
PL3393565T3 PL16826768.0T PL16826768T PL3393565T3 PL 3393565 T3 PL3393565 T3 PL 3393565T3 PL 16826768 T PL16826768 T PL 16826768T PL 3393565 T3 PL3393565 T3 PL 3393565T3
Authority
PL
Poland
Prior art keywords
nicotine particle
particle capsule
capsule
nicotine
particle
Prior art date
Application number
PL16826768.0T
Other languages
English (en)
Inventor
Gerard Zuber
Nicolo VOLPE
Original Assignee
Philip Morris Products S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products S.A. filed Critical Philip Morris Products S.A.
Publication of PL3393565T3 publication Critical patent/PL3393565T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241Extraction of specific substances
    • A24B15/243Nicotine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/186Treatment of tobacco products or tobacco substitutes by coating with a coating composition, encapsulation of tobacco particles
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F15/00Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor
    • A24F15/01Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/20Devices without heating means
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/60Constructional details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • A61M15/0035Piercing means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
PL16826768.0T 2015-12-24 2016-12-19 Kapsułki z cząsteczkami nikotyny PL3393565T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15202712 2015-12-24
EP16201580 2016-11-30
PCT/IB2016/057792 WO2017109678A1 (en) 2015-12-24 2016-12-19 Nicotine particle capsule

Publications (1)

Publication Number Publication Date
PL3393565T3 true PL3393565T3 (pl) 2023-09-11

Family

ID=57822002

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16826768.0T PL3393565T3 (pl) 2015-12-24 2016-12-19 Kapsułki z cząsteczkami nikotyny

Country Status (18)

Country Link
US (1) US10960152B2 (pl)
EP (1) EP3393565B1 (pl)
JP (1) JP7242300B2 (pl)
KR (1) KR20180096611A (pl)
CN (1) CN108430551A (pl)
AU (1) AU2016376033A1 (pl)
BR (1) BR112018010830B1 (pl)
CA (1) CA3008996A1 (pl)
ES (1) ES2948157T3 (pl)
IL (1) IL259910A (pl)
MX (1) MX2018007512A (pl)
PH (1) PH12018501199A1 (pl)
PL (1) PL3393565T3 (pl)
RU (1) RU2720573C2 (pl)
SG (1) SG11201805204WA (pl)
UA (1) UA123586C2 (pl)
WO (1) WO2017109678A1 (pl)
ZA (1) ZA201803662B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7069197B2 (ja) 2017-02-28 2022-05-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 粉末脱凝集アクチュエータを備えるエアロゾル発生装置
BR112019025635A2 (pt) * 2017-06-28 2020-06-23 Philip Morris Products S.A. Recipiente com partículas para uso com inalador
KR20200077514A (ko) * 2017-10-25 2020-06-30 필립모리스 프로덕츠 에스.에이. 경계 요소를 가지는 흡입기
CN114642275A (zh) * 2017-10-25 2022-06-21 菲利普莫里斯生产公司 用于吸入器制品和系统的刺穿附件
US11744960B2 (en) 2017-12-28 2023-09-05 Philip Morris Products S.A. Inhaler with vortex tunnel
CN111526747B (zh) * 2018-02-19 2023-11-07 菲利普莫里斯生产公司 干粉吸入器
JP7458985B2 (ja) 2018-03-26 2024-04-01 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 複合多孔性支持要素を備えた吸入器
BR112020016528A2 (pt) * 2018-03-26 2020-12-15 Philip Morris Products S.A. Inalador com elemento de suporte poroso com abertura
BR112020016652A2 (pt) 2018-03-26 2020-12-15 Philip Morris Products S.A. Inalador com cavidade de cápsula de vórtice

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4695274A (en) 1986-01-31 1987-09-22 Fox Richard L Protected hypodermic needle
US4790305A (en) 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
US4735217A (en) 1986-08-21 1988-04-05 The Procter & Gamble Company Dosing device to provide vaporized medicament to the lungs as a fine aerosol
GB8804069D0 (en) 1988-02-22 1988-03-23 Britains Petite Ltd Dispensers for powdered medication
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
NO168921C (no) 1989-07-31 1992-04-22 Svein Knudsen Roekfri sigaretterstatning til bruk ved roekavvenning ellertil bruk i roekfrie miljoeer
US5441060A (en) 1993-02-08 1995-08-15 Duke University Dry powder delivery system
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
US6102036A (en) 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6234169B1 (en) * 1998-08-14 2001-05-22 Arthur Slutsky Inhaler
GB0009468D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US20040206350A1 (en) 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050081852A1 (en) * 2002-12-30 2005-04-21 Nektar Therapeutics (Formely Inhale Therapeutic System Inc.) Package for an aerosolization apparatus and pharmaceutical formulation receptacle
US7669596B2 (en) * 2002-12-31 2010-03-02 Novartis Pharma Ag Aerosolization apparatus with rotating capsule
CA2511523C (en) * 2002-12-31 2013-10-15 Nektar Therapeutics Pharmaceutical formulation with an insoluble active agent for pulmonary administration
US20050056280A1 (en) * 2002-12-31 2005-03-17 Nektar Therapeutics Receptacle for an aerosolizable pharmaceutical formulation
DE602004014909D1 (de) * 2003-03-20 2008-08-21 Galephar M F Verbessertes trockenpulver-inhalationssystem
WO2004112702A2 (en) * 2003-06-13 2004-12-29 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
GB2415597A (en) * 2004-07-01 2006-01-04 Christopher Owen Hackling Cigarette
ATE443658T1 (de) 2005-11-21 2009-10-15 Mannkind Corp Pulverabgabe und -erfassungsvorrichtung und - verfahren
GB2461008B (en) 2006-12-08 2011-08-10 Exchange Supplies Ltd Nicotine inhalation device
US10668058B2 (en) 2007-03-30 2020-06-02 Philip Morris Products S.A. Device and method for delivery of a medicament
AU2008335821B2 (en) 2007-12-05 2012-12-20 Novartis Ag Receptacle for an aerosolizable pharmaceutical formulation
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
AT507631B1 (de) * 2008-11-26 2012-05-15 Haas Rouven Mag Vorrichtung zum ansaugen von pulver- oder granulat-material und kapsel hierfür
CN102395398B (zh) 2009-02-23 2016-03-16 日本烟草产业株式会社 非加热型烟草香味吸取器
US8813759B1 (en) 2010-11-18 2014-08-26 Richard C. Horian Nicotine inhaler and method of manufacture
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
JP6037315B2 (ja) 2011-05-27 2016-12-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入器及び吸入器用カプセル
EP2731572B1 (en) 2011-07-13 2021-04-07 Pharmaxis Ltd. Improvements relating to delivery devices
US20140088045A1 (en) 2012-09-21 2014-03-27 Basil Rigas Product comprising a nicotine-containing material and an anti-cancer agent
EP3136894B1 (en) * 2014-04-28 2019-07-31 Philip Morris Products S.A. Nicotine powder inhaler
AU2015254999B2 (en) 2014-04-28 2019-08-01 Philip Morris Products S.A. Flavoured nicotine powder inhaler
JP6718383B2 (ja) * 2014-06-20 2020-07-08 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 管理手段を備えたニコチン粉末送達システム
PL3160271T3 (pl) * 2014-06-27 2020-05-18 Philip Morris Products S.A. Układ wytwarzania aerozolu z ulepszonym elementem przebijającym
US11033692B2 (en) * 2015-04-15 2021-06-15 Philip Morris Products S.A. Flavoring element for an inhalation device
US20170071248A1 (en) * 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations

Also Published As

Publication number Publication date
EP3393565A1 (en) 2018-10-31
WO2017109678A1 (en) 2017-06-29
CA3008996A1 (en) 2017-06-29
MX2018007512A (es) 2018-09-17
RU2018126867A3 (pl) 2020-03-17
IL259910A (en) 2018-07-31
JP2019508015A (ja) 2019-03-28
RU2720573C2 (ru) 2020-05-12
CN108430551A (zh) 2018-08-21
KR20180096611A (ko) 2018-08-29
JP7242300B2 (ja) 2023-03-20
RU2018126867A (ru) 2020-01-24
SG11201805204WA (en) 2018-07-30
BR112018010830A2 (pt) 2018-11-27
UA123586C2 (uk) 2021-04-28
EP3393565B1 (en) 2023-05-24
ZA201803662B (en) 2019-07-31
AU2016376033A1 (en) 2018-06-28
BR112018010830B1 (pt) 2023-04-11
ES2948157T3 (es) 2023-09-01
US20190001084A1 (en) 2019-01-03
US10960152B2 (en) 2021-03-30
PH12018501199A1 (en) 2019-01-28

Similar Documents

Publication Publication Date Title
ZA201702202B (en) Capsule composition
IL259910A (en) Nicotine particle capsule
ZA201606073B (en) Nicotine powder inhaler
HK1256041A1 (zh) 乾粉吸入器
LT3505209T (lt) Miltelių inhaliatorius
GB201608157D0 (en) Capsules
IL263340A (en) nicotine particles
ZA201703077B (en) Dry powder inhaler
GB201618176D0 (en) Powder removal
PL3138601T3 (pl) Inhalator suchego proszku
PL3328361T3 (pl) Cząstki nanożywicy zawierające lek
GB201411526D0 (en) Powder
PL3368184T3 (pl) Skrócona kapsuła filtra
IL259936B (en) Flavored nicotine powder
IL249773A0 (en) Breaks up lumps of dry powder medicine
IL259959A (en) Oxygen-generating capsule
GB2577405B (en) Particle
IL247557A0 (en) Nicotine powder inhaler
GB201601923D0 (en) Matches/capsule
GB201509603D0 (en) Tobacco etc capsule/tin
AU362816S (en) Capsule
GB201509538D0 (en) Hellum capsules
GB201511411D0 (en) Kanby tobacco
GB201421585D0 (en) Capsule composition
AU358389S (en) Pharmaceutical capsule